TRCT
BVS icon

Tower Research Capital (TRC)’s Bioventus BVS Stock Holding History

Tower Research Capital (TRC)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6K Buy
4,199
+2,434
+138% +$23.2K ﹤0.01% 2932
2026
Q1 		$16.1K Buy
1,765
+464
+36% +$3.89K ﹤0.01% 3631
2025
Q4 		$9.68K Sell
1,301
-671
-34% -$4.82K ﹤0.01% 3884
2025
Q3 		$13.2K Sell
1,972
-3,465
-64% -$24K ﹤0.01% 3712
2025
Q2 		$36K Buy
5,437
+2,498
+85% +$17.7K ﹤0.01% 3250
2025
Q1 		$26.9K Sell
2,939
-530
-15% -$5.29K ﹤0.01% 2696
2024
Q4 		$36.4K Buy
3,469
+1,786
+106% +$21.1K ﹤0.01% 2762
2024
Q3 		$20.1K Buy
+1,683
New +$14.6K ﹤0.01% 3235
2024
Q2 		– Sell
-5,051
Closed -$26.3K – 5707
2024
Q1 		$26.3K Buy
5,051
+1,438
+40% +$7.03K ﹤0.01% 2761
2023
Q4 		$19K Sell
3,613
-19,478
-84% -$77.1K ﹤0.01% 3679
2023
Q3 		$76.2K Buy
23,091
+16,878
+272% +$59.2K ﹤0.01% 2195
2023
Q2 		$18K Sell
6,213
-5,258
-46% -$10.1K ﹤0.01% 3483
2023
Q1 		$12K Buy
11,471
+4,590
+67% +$8.78K ﹤0.01% 4053
2022
Q4 		$18K Sell
6,881
-11,555
-63% -$50.5K ﹤0.01% 3204
2022
Q3 		$129K Buy
18,436
+4,060
+28% +$31.8K ﹤0.01% 2330
2022
Q2 		$98K Buy
14,376
+13,853
+2,649% +$141K ﹤0.01% 2310
2022
Q1 		$7K Sell
523
-404
-44% -$5.41K ﹤0.01% 4698
2021
Q4 		$13K Buy
927
+246
+36% +$3.5K ﹤0.01% 4153
2021
Q3 		$10K Buy
681
+153
+29% +$2.35K ﹤0.01% 4303
2021
Q2 		$10K Sell
528
-850
-62% -$13.7K ﹤0.01% 4374
2021
Q1 		$21K Buy
+1,378
New +$19.6K ﹤0.01% 3834

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s BVS Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Bioventus (BVS) stake by 138% in Q2 2026, buying an estimated $23.2K and bringing the position to 4,199 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Tower Research Capital (TRC) first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $129K in Q3 2022. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Tower Research Capital (TRC) held 4,199 shares of Bioventus worth $39.6K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,434 Bioventus shares in Q2 2026, an estimated $23.2K.
  • Bioventus made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2932 holding.
  • Tower Research Capital (TRC) first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Bioventus position peaked at $129K in Q3 2022.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.